Related Experiment Video
Updated: Jul 1, 2026

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells
Published on: August 12, 2015
Glucose-regulated protein 78 as a novel effector of BRCA1 for inhibiting stress-induced apoptosis
B H Y Yeung1, B W Y Kwan, Q Y He
1School of Biological Sciences, University of Hong Kong, Hong Kong, China.
Abstract:
The tumor suppressor BRCA1 is mutated in a high percentage of familial breast and ovarian cancer, but our understanding of its mechanisms of action remains incomplete. We report here that glucose-regulated protein (GRP)-78, a critical regulator of the unfolded protein response (UPR), is a novel downstream target of BRCA1. We showed that overexpression of wild-type BRCA1 suppressed the expression of GRP78, whereas expression of mutant BRCA1 gene or targeted inhibition of endogenous BRCA1 using small-interfering RNA (siRNA) enhanced GRP78 expression. Knockdown of BRCA1 also led to induction of other components of UPR, such as GRP94 and CHOP. Consistent with a role of BRCA1 knockdown in mediating cell survival, forced expression of GRP78 stimulated cell proliferation and prevented apoptosis, including that induced by endoplasmic reticulum stress and chemotherapy, in ovarian OVCAR-3 and breast MCF-7 cancer cells. Overexpression of wild-type BRCA1 could increase the apoptosis of GRP78-overexpressing cells. Conversely, knockdown GRP78 by siRNA sensitized ovarian and breast cancer cells to apoptosis. This effect was reduced when the expression of BRCA1 was simultaneously knockdown by siRNA, indicating that BRCA1 also negatively regulates GRP78-mediated cell survival and resistance to apoptosis.
Insights
The tumor suppressor BRCA1 regulates the unfolded protein response (UPR) by targeting glucose-regulated protein (GRP)-78. BRCA1 suppresses GRP78, impacting cancer cell survival and apoptosis.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Biology
Background:
- The tumor suppressor BRCA1 is frequently mutated in familial breast and ovarian cancers.
- BRCA1's precise mechanisms of action are not fully understood.
- The unfolded protein response (UPR) is crucial for cellular homeostasis and is implicated in cancer progression.
Purpose of the Study:
- To investigate the relationship between BRCA1 and the UPR.
- To identify GRP78 as a novel downstream target of BRCA1.
- To elucidate BRCA1's role in regulating cancer cell survival and apoptosis via GRP78.
Main Methods:
- Overexpression of wild-type and mutant BRCA1.
- Small interfering RNA (siRNA) mediated knockdown of BRCA1 and GRP78.
- Analysis of GRP78, GRP94, and CHOP expression.
- Assessment of cell proliferation and apoptosis in ovarian (OVCAR-3) and breast (MCF-7) cancer cells.
Main Results:
- Wild-type BRCA1 overexpression suppressed GRP78 expression, while BRCA1 inhibition enhanced it.
- BRCA1 knockdown induced other UPR components (GRP94, CHOP).
- Forced GRP78 expression promoted proliferation and inhibited apoptosis, whereas GRP78 knockdown sensitized cells to apoptosis.
Conclusions:
- BRCA1 acts as a negative regulator of GRP78 expression.
- BRCA1 influences cancer cell survival and apoptosis by modulating GRP78.
- Targeting the BRCA1-GRP78 axis may offer therapeutic strategies for breast and ovarian cancers.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cell Specific Gene Expression
Negative Regulator Molecules
Abnormal Proliferation
Regulation of the Unfolded Protein Response
DNA Damage can Stall the Cell Cycle

